Breaking News Instant updates and real-time market news.

BG

Bunge

$74.60

-4.45 (-5.63%)

06:25
02/15/18
02/15
06:25
02/15/18
06:25

Bunge upgraded to Overweight from Equal Weight at Stephens

  • 30

    May

BG Bunge
$74.60

-4.45 (-5.63%)

01/23/18
JPMS
01/23/18
NO CHANGE
JPMS
Underweight
Glencore better fit for Bunge than ADM, says JPMorgan
JPMorgan analyst Ann Duignan believes Bunge (BG) is a "superior strategic fit" for Glencore (GLNCY) and "clearly not in-line" with the strategic vision communicated by ADM (ADM) in recent years. The analyst has an Underweight rating on ADM shares and does not rate Bunge. The Wall Street Journal reported Friday that ADM made a takeover approach to Bunge. Dunigan does not believe Bunge's core assets would be easily separable without destroying value, and therefore does not think it would be possible for both ADM and Glencore to share the company. Further, ADM does not have the fire power to outbid Glencore and its partners, the analyst told investors yesterday in a research note.
01/22/18
FBCO
01/22/18
NO CHANGE
Target $84
FBCO
Outperform
Credit Suisse says Archer may be trying to push Bunge to negotiating table
Credit Suisse analyst Robert Moskow said that by making its interest public via a Wall Street Journal report, Archer Daniels (ADM) might be trying to get Bunge (BG) to the negotiating table before its standstill agreement with Glencore (GLNCY) expires in February. He has heard speculation that Archer might just want to make sure Glencore pays up, but Moskow believes this approach sound like more than just "friendly fire," he tells investors. Given Archer Daniels' unleveraged balance sheet and significant overlap with Bunge, the analyst estimates $800M of headline synergies and a $90 per share price for Bunge are possible. Moskow keeps an Outperform rating and $84 price target on Bunge shares, which are up about 4% to $80.45 near midday.
01/22/18
SBSH
01/22/18
NO CHANGE
SBSH
Citi sees $85-$100 per share as 'appropriate' deal price for Bunge
Citi analyst David Driscoll believes $85-$100 per share is an "appropriate" takeover price for Archer Daniels Midland (ADM) to pay for Bunge (BG). The Wall Street Journal on Friday reported that ADM has made a takeover approach towards Bunge. "Back of the envelope" deal math at the midpoint of the takeout range suggests accretion to ADM of 75c per share, 28% against a 2018 earnings per share of forecast of $2.70, Driscoll tells investors in a research note. He believes, however, that there could be some antitrust issues in ADM and Bunge's oilseed processing businesses in the U.S. and Europe. Antitrust hurdles in both countries are "likely high" for a possible combination, the analyst contends. Further, he believes that if ADM is unable to hold onto Bunge's North American and European crushing assets in a deal, the transaction would be less attractive.
01/22/18
SPHN
01/22/18
NO CHANGE
Target $72
SPHN
Equal Weight
Bunge could be valued at $90-$95 in takeover, says Stephens
After The Wall Street Journal reported that Archer Daniels Midlands (ADM) made a takeover approach to Bunge (BG), Stephens analyst Farha Aslam noted the prior reports that Glencore (GLNCY) had sought to buy Bunge last May and has a stand still agreement in place that expires in February. She believes that Bunge could be valued at $90-$95 in a takeover scenario and notes that synergies from a combination with Archer Daniels would likely be significant. Aslam keeps an Equal Weight rating and $72 price target on Bunge shares.

TODAY'S FREE FLY STORIES

ADBE

Adobe

$247.71

2.27 (0.92%)

07:27
12/14/18
12/14
07:27
12/14/18
07:27
Recommendations
Adobe analyst commentary  »

Adobe valuation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

COST

Costco

$226.41

-1.41 (-0.62%)

07:25
12/14/18
12/14
07:25
12/14/18
07:25
Recommendations
Costco analyst commentary  »

Costco price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

V

Visa

$137.58

-0.26 (-0.19%)

07:25
12/14/18
12/14
07:25
12/14/18
07:25
Conference/Events
Visa management to meet with Wedbush »

Meeting to be held in San…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

  • 29

    Jan

BECN

Beacon Roofing

$31.84

-0.22 (-0.69%)

07:24
12/14/18
12/14
07:24
12/14/18
07:24
Downgrade
Beacon Roofing rating change  »

Beacon Roofing downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

REG

Regency Centers

$62.26

0.06 (0.10%)

07:24
12/14/18
12/14
07:24
12/14/18
07:24
Downgrade
Regency Centers rating change  »

Regency Centers…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Feb

DRGDF

Detour Gold

$0.00

(0.00%)

07:19
12/14/18
12/14
07:19
12/14/18
07:19
Downgrade
Detour Gold rating change  »

Detour Gold downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MCD

McDonald's

$186.53

2.99 (1.63%)

, YUM

Yum! Brands

$93.49

3.02 (3.34%)

07:19
12/14/18
12/14
07:19
12/14/18
07:19
Recommendations
McDonald's, Yum! Brands analyst commentary  »

JPMorgan calls…

MCD

McDonald's

$186.53

2.99 (1.63%)

YUM

Yum! Brands

$93.49

3.02 (3.34%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NNN

National Retail Properties

$50.86

0.94 (1.88%)

07:18
12/14/18
12/14
07:18
12/14/18
07:18
Downgrade
National Retail Properties rating change  »

National Retail…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DRGDF

Detour Gold

$0.00

(0.00%)

07:16
12/14/18
12/14
07:16
12/14/18
07:16
Downgrade
Detour Gold rating change  »

Detour Gold downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BLCM

Bellicum Pharmaceuticals

$3.60

-0.155 (-4.13%)

07:15
12/14/18
12/14
07:15
12/14/18
07:15
Hot Stocks
Bellicum Pharmaceuticals reports data from BPX-601 at ESMO-IO »

Bellicum Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

THG

Hanover Insurance

$109.52

-0.68 (-0.62%)

07:14
12/14/18
12/14
07:14
12/14/18
07:14
Conference/Events
Hanover Insurance management to meet with Buckingham »

Meeting to be held in San…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

  • 19

    Dec

BHC

Bausch Health

$23.65

-0.47 (-1.95%)

07:12
12/14/18
12/14
07:12
12/14/18
07:12
Upgrade
Bausch Health rating change  »

Bausch Health upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Feb

  • 25

    Feb

IDRA

Idera Pharmaceuticals

$6.60

-0.06 (-0.90%)

07:10
12/14/18
12/14
07:10
12/14/18
07:10
Hot Stocks
Idera Pharmaceuticals presents data from Phase 2 expansion of ILUMMINATE-204 »

Idera Pharmaceuticals has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

RBA

Ritchie Bros.

$32.39

-0.28 (-0.86%)

07:08
12/14/18
12/14
07:08
12/14/18
07:08
Hot Stocks
Ritchie Bros. sells C$639M+ of equipment in Edmonton auction »

Ritchie Bros. held its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SBUX

Starbucks

$66.90

0.8 (1.21%)

07:07
12/14/18
12/14
07:07
12/14/18
07:07
Recommendations
Starbucks analyst commentary  »

Starbucks story regaining…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

VLKAY

Volkswagen

$0.00

(0.00%)

, DDAIF

Daimler AG

$0.00

(0.00%)

07:07
12/14/18
12/14
07:07
12/14/18
07:07
Hot Stocks
EU passenger car registrations down 8.0% in November »

In November, passenger…

VLKAY

Volkswagen

$0.00

(0.00%)

DDAIF

Daimler AG

$0.00

(0.00%)

NSANY

Nissan

$0.00

(0.00%)

TM

Toyota

$120.89

-1.04 (-0.85%)

F

Ford

$8.50

-0.135 (-1.56%)

HMC

Honda

$27.23

-0.03 (-0.11%)

GM

General Motors

$35.11

-0.58 (-1.63%)

FCAU

Fiat Chrysler

$15.67

-0.18 (-1.14%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Jan

  • 23

    Jan

  • 25

    Apr

  • 24

    Jul

  • 23

    Oct

CPRX

Catalyst Pharmaceuticals

$2.47

0.075 (3.14%)

07:06
12/14/18
12/14
07:06
12/14/18
07:06
Recommendations
Catalyst Pharmaceuticals analyst commentary  »

Catalyst Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

REXR

Rexford Industrial

$31.42

0.09 (0.29%)

07:06
12/14/18
12/14
07:06
12/14/18
07:06
Hot Stocks
Rexford Industrial acquires industrial property for $18.2M »

Rexford Industrial Realty…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

COST

Costco

$226.41

-1.41 (-0.62%)

07:05
12/14/18
12/14
07:05
12/14/18
07:05
Recommendations
Costco analyst commentary  »

Costco price target cut…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

07:05
12/14/18
12/14
07:05
12/14/18
07:05
General news
Futures lower after underwhelming Chinese data »

Stock futures are…

LPTX

Leap Therapeutics

$2.85

-0.27 (-8.65%)

07:04
12/14/18
12/14
07:04
12/14/18
07:04
Hot Stocks
Leap Therapeutics presents final data from the Phase I/II study of DKN-01 »

Leap provided the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CIEN

Ciena

$34.90

2.765 (8.60%)

07:04
12/14/18
12/14
07:04
12/14/18
07:04
Recommendations
Ciena analyst commentary  »

Ciena price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LPTX

Leap Therapeutics

$2.85

-0.27 (-8.65%)

07:03
12/14/18
12/14
07:03
12/14/18
07:03
Hot Stocks
Leap Therapeutics presents TRX518 data at ESMO »

Leap Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TTD

Trade Desk

$139.16

-4.28 (-2.98%)

07:03
12/14/18
12/14
07:03
12/14/18
07:03
Recommendations
Trade Desk analyst commentary  »

Trade Desk price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BCEI

Bonanza Creek

$25.01

-0.26 (-1.03%)

07:02
12/14/18
12/14
07:02
12/14/18
07:02
Initiation
Bonanza Creek initiated  »

Bonanza Creek initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.